Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

1581973

registered interest
date	30/01/2023
answering body	Northern Ireland Office
answering dept id	21
answering dept short name	Northern Ireland
answering dept sort name	Northern Ireland
hansard heading	Cycling and Walking: Northern Ireland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Northern Ireland, what steps he is taking to support the Northern Ireland Department for Infrastructure to spend 10 per cent of the transport budget on active travel.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	135337
answer	answer is ministerial correction date of answer 02/02/2023 answer text <p>Responsibility for transport policy is devolved to the Northern Ireland Executive and the Department for Infrastructure.</p><p> </p><p>The UK Government recognises the importance of active travel, and through the “Communities and Place” strand of the UK Shared Prosperity Fund (UKSPF), will provide support for active travel enhancement, including proposals to undertake active travel needs assessments and explore active travel links.</p><p> </p><p>All 11 Northern Ireland councils have been invited by the Department for Levelling Up, Housing and Communities to bid for UKSPF funding to deliver such programmes. These bids are currently undergoing assessment.</p><p> </p> answering member constituency Wycombe answering member printed Mr Steve Baker question first answered 02/02/2023 11:43:14 answering member 4064 label Biography information for Mr Steve Baker
tabling member	4131 label Biography information for Jim Shannon

1581112

registered interest
date	26/01/2023
answering body	Cabinet Office
answering dept id	53
answering dept short name	Cabinet Office
answering dept sort name	Cabinet Office
hansard heading	Heatstroke: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Minister for the Cabinet Office, how many people have died of heat stroke in the UK in the last ten years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	133592
answer	answer is ministerial correction date of answer 31/01/2023 answer text <p>The information requested falls under the remit of the UK Statistics Authority.</p><p>A response to the Hon. Member's Parliamentary Question of 26 January is attached.</p><p> </p> answering member constituency Horsham answering member printed Jeremy Quin question first answered 31/01/2023 17:10:26 answering member 4507 label Biography information for Sir Jeremy Quin attachment 1 file name PQ133592 .pdf title UKSA Response to PQ133592
tabling member	4131 label Biography information for Jim Shannon

1581115

registered interest
date	26/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Scarlet Fever and Streptococcus: Antibiotics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the supply of antibiotics to help tackle (a) Strep A and (b) Scarlet Fever.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	133595
answer	answer is ministerial correction date of answer 01/02/2023 answer text <p>We have taken decisive action to boost supply of antibiotics used to treat Strep A and demand has reduced. We are continuing to work with manufacturers and wholesalers to ensure that they expedite deliveries, bring forward stock they have to make sure it gets to where it is needed and boost supply to meet demand. We have issued eight Serious Shortage Protocols to allow pharmacists to supply an alternative form of penicillin V, or alternative antibiotic, to make things easier for them, patients and general practices.</p> answering member constituency Colchester answering member printed Will Quince question first answered 01/02/2023 15:06:30 answering member 4423 label Biography information for Will Quince
tabling member	4131 label Biography information for Jim Shannon

1580744

registered interest
date	25/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the implications for his policies of the report on Transforming lives, improving health outcomes: tackling the true cost of variation in uptake of innovative medicines, published by the NHS Confederation and the Association of the British Pharmaceutical Industry in January 2023; and what steps he is taking to reduce such variation across the UK.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	132363
answer	answer is ministerial correction date of answer 30/01/2023 answer text <p>As outlined in the ambitious Life Sciences Vision, which was co-developed with industry following extensive engagement with stakeholders from charities, patient interest groups, the National Health Service and devolved administrations, the Government is committed to going further and addressing concerns about the uptake and spread of proven innovations, with a particular focus on identifying and addressing any unwarranted variation in uptake.</p><p>Existing reporting tools, such as NHS Digital’s Innovation Scorecard, monitor the use of innovative medicines. To further analyse the extent of regional variation in the uptake of National Institute for Health and Care Excellence approved medicines, the Office for Life Sciences is working with NHS England and jointly engaging with stakeholders across the health system to understand the drivers of variation and the barriers to equitable uptake.</p> answering member constituency Colchester answering member printed Will Quince question first answered 30/01/2023 17:01:43 answering member 4423 label Biography information for Will Quince
tabling member	4131 label Biography information for Jim Shannon

1580745

registered interest
date	25/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help increase the uptake and availability of innovative medicines across the UK.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	132364
answer	answer is ministerial correction date of answer 30/01/2023 answer text <p>The Government wants National Health Service patients to benefit from access to effective new medicines in a way that represents value and is fair to all parties. The National Institute for Health and Care Excellence (NICE) develops guidance for the NHS on whether all new medicines represent a clinically and cost effective use of NHS resources and aims to publish guidance on new medicines as close as possible to the point of licensing. The NHS in England is legally required to make funding available for NICE recommended treatments. As part of the appraisal process, companies are able to agree commercial arrangements in line with the NHS Commercial Framework.</p><p>NICE recommends the vast majority of medicines for use in the NHS, whether for routine commissioning or through the Cancer Drugs Fund. NICE is also now able to recommend non-cancer medicines for use through the Innovative Medicines Fund.</p><p>The Government established the Accelerated Access Collaborative (AAC), the umbrella organisation overseeing the health ecosystem, to bring together leaders from across the life sciences sector and tackle the barriers to adoption of innovation in the NHS. The AAC is delivering real success. In 2021/22, the AAC supported over 570,000 patients with access to proven innovations, secured £445 million of investment, supported 3,000 innovations and created and safeguarded over 3,900 jobs.</p><p>As outlined in the ambitious Life Sciences Vision, which was co-developed with industry, the Government is committed to going further and addressing concerns about the uptake and spread of proven innovations, with a particular focus on identifying and addressing any unwarranted variation in uptake. The AAC will continue to be at the forefront of this agenda and work is underway to consider how to best utilise regional, local and frontline delivery partners to support the adoption and spread of proven innovations.</p> answering member constituency Colchester answering member printed Will Quince question first answered 30/01/2023 17:00:35 answering member 4423 label Biography information for Will Quince
tabling member	4131 label Biography information for Jim Shannon

1580748

registered interest
date	25/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help secure international agreements to support (a) access to and investment in R&D and (b) cost effective procurement of medicines for the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	132367
answer	answer is ministerial correction date of answer 01/02/2023 answer text <p>The Department has an international function that maintains relationships with other ministries of health and international organisations, such as the World Health Organization. Through these relationships, we create and maintain opportunities for Government to secure international agreements to support access to and investment in research and development and advance policies that protect the health of United Kingdom citizens and improve health for people around the world.</p> answering member constituency Colchester answering member printed Will Quince question first answered 01/02/2023 14:24:03 answering member 4423 label Biography information for Will Quince
tabling member	4131 label Biography information for Jim Shannon

1580063

registered interest
date	24/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccination: Take-up
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 December 2022 to Question 94752 on Vaccination, with reference to the findings of the UK Health Security Agency's reports on (a) Pneumococcal Polysaccharide Vaccine (PPV) coverage report, England, April 2020 to March 2021, dated 23 November 2021 and (b) Shingles vaccine coverage (England): annual report of the financial year 2021 to 2022, last updated 11 November 2022, what steps his Department is taking to increase vaccine uptake.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	131164
answer	answer is ministerial correction date of answer 01/02/2023 answer text <p>The Department works with the UK Health Security Agency (UKHSA) and the NHS to improve immunisation access by providing clear, accurate information about eligibility, and the benefits of vaccines.</p><p>For both the adult pneumococcal and shingles vaccinations, general practices (GPs) proactively invite patients to come forward throughout the year when they reach the eligible age. GPs also provide these vaccines opportunistically when patients visit their GP for any other reason. The Department encourages anyone unsure of their vaccination status or eligibility, to contact their GP for advice.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 01/02/2023 17:43:19 answering member 4492 label Biography information for Maria Caulfield
tabling member	4131 label Biography information for Jim Shannon

1580064

registered interest
date	24/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department takes to ensure that the Joint Committee on Vaccination and Immunisation reviews new vaccines and immunisations (a) shortly after marketing authorisation and (b) in a timely manner.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	131165
answer	answer is ministerial correction date of answer 01/02/2023 answer text <p>The Department works with the UK Health Security Agency (UKHSA) to ensure that the Joint Committee on Vaccination and Immunisation is resourced to undertake reviews of newly authorised vaccines in a timely manner following market authorisation.</p><p> </p><p>The timetable for such consideration is dependent on a number of factors including the current burden of disease to the population, whether an effective vaccine is already in use, the amount of evidence available and whether further evidence is required to reach a clear decision.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 01/02/2023 17:40:52 answering member 4492 label Biography information for Maria Caulfield
tabling member	4131 label Biography information for Jim Shannon

1580065

registered interest
date	24/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the Government has considered introducing an accelerated regulatory and approval pathway for new vaccines and immunisations, particularly for diseases where an effective vaccine does not yet exist.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	131166
answer	answer is ministerial correction date of answer 31/01/2023 answer text <p>There are no current plans to introduce alternative accelerated approval pathways specific to vaccines and immunisations. At present, where accelerated approval of a vaccine is necessary, a medicine can be assessed for temporary authorisation under Regulation 174. This permits the supply of vaccine batches based on the safety, quality and efficacy data submitted by the applicant to the Medicines and Healthcare products Regulatory Agency (MHRA). This authorisation is not a marketing authorisation and only applies to supply within the United Kingdom of Great Britain and Northern Ireland.</p><p>Apart from Regulation 174, there are other regulatory routes in place for new medicines and vaccines. These regulatory routes may include (Conditional) Marketing Authorizations as well as Innovative Licensing and Access Pathway and Access Consortium approval procedures.</p><p>The Conditional Marketing Authorisation (CMA) route is particularly suited to vaccines for prevention of serious infectious diseases where no vaccine exists currently. This route allows for the possibility of authorisation earlier in the development pathway, before confirmatory data are available. New vaccines would be eligible for the accelerated, 150 day, assessment procedure.</p> answering member constituency Colchester answering member printed Will Quince question first answered 31/01/2023 12:53:00 answering member 4423 label Biography information for Will Quince
tabling member	4131 label Biography information for Jim Shannon

1580201

registered interest
date	24/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Staff
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to publish the NHS England long-term workforce plan.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	131190
answer	answer is ministerial correction date of answer 01/02/2023 answer text <p>The Government has committed to publishing the workforce plan this year and this will include independently verified projections for the number of doctors, nurses and other professionals that will be needed in five, 10 and 15 years’ time, taking full account of improvements in retention and productivity.</p><p>This plan will help ensure that we have the right numbers of staff, with the right skills to transform and deliver high quality services fit for the future.</p> answering member constituency Colchester answering member printed Will Quince question first answered 01/02/2023 14:27:04 answering member 4423 label Biography information for Will Quince
tabling member	4131 label Biography information for Jim Shannon